RESEARCHER PROFILE
Saeed Mohammadi
← Back to Golestan University of Medical Sciences
S
Golestan University of Medical Sciences
Saeed Mohammadi works in Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, MicroRNA in disease regulation. Recorded institutional associations include Golestan University, University of Nizwa, Golestan University of Medical Sciences.
81Publications
1,177Citations
17H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
2019 · 262 citationsImmunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor
2018 · 71 citationsGlobal burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025 · 71 citationsImmunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone
2017 · 54 citationsIndole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line
2017 · 42 citationsSodium valproate modulates immune response by alternative activation of monocyte-derived macrophages in systemic lupus erythematosus
2017 · 38 citationsMetabolic reprogramming in viral infections: the interplay of glucose metabolism and immune responses
2025 · 37 citationsCOVID-19: The Immune Responses and Clinical Therapy Candidates
2020 · 33 citationsInterleukin10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population
2018 · 32 citationsDysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21
2019 · 30 citationsIL-17 is Aberrantly Overexpressed Among Under-treatment Systemic Lupus Erythematosus Patients
2019 · 25 citationsPrediction of HBF-0259 interactions with hepatitis B Virus receptors and surface antigen secretory factors
2016 · 20 citationsGlucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus
2017 · 20 citationsNiosomal Curcumin Suppresses IL17/IL23 Immunopathogenic Axis in Skin Lesions of Psoriatic Patients: A Pilot Randomized Controlled Trial
2023 · 19 citationsImplications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies
2024 · 19 citationsEffects of berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line.
2017 · 18 citationsEffects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells.
2016 · 17 citationsSimultaneous disruption of circulating miR‐21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC)
2021 · 17 citationsAssociation between interleukin‐10 gene polymorphisms and severe chronic periodontitis
2019 · 16 citationsEffect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay
2020 · 16 citationsSerum and salivary tissue transglutaminase IGA (tTG-IGA) level in celiac patients
2022 · 16 citationsOverexpression of interferon-γ and indoleamine 2, 3-dioxygenase in systemic lupus erythematosus: relationship with the disease activity
2017 · 15 citationsAugmenting the Antitumor Efficacy of Natural Killer Cells via SynNotch Receptor Engineering for Targeted IL-12 Secretion
2024 · 14 citationsThe Impaired Balance of CD4+/CD8+ Ratio in Patients with Chronic Hepatitis B
2020 · 12 citationsEncapsulation of Leflunomide (LFD) in a novel niosomal formulation facilitated its delivery to THP-1 monocytic cells and enhanced Aryl hydrocarbon receptor (AhR) nuclear translocation and activation
2019 · 11 citations